Page last updated: 2024-08-21

fluorobenzenes and Parkinson Disease

fluorobenzenes has been researched along with Parkinson Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boger, HA; Corum, D; Lynn, MK; Schnellmann, RG; Scholpa, NE1
Bonhaus, DW; McFarland, K; Price, DL1
Orr, JD1

Reviews

1 review(s) available for fluorobenzenes and Parkinson Disease

ArticleYear
Statins in the spectrum of neurologic disease.
    Current atherosclerosis reports, 2008, Volume: 10, Issue:1

    Topics: Alzheimer Disease; Animals; Atherosclerosis; Cardiovascular Diseases; Diabetic Neuropathies; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Multiple Sclerosis; Nervous System Diseases; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Pyrimidines; Reactive Oxygen Species; Rosuvastatin Calcium; Stroke; Sulfonamides

2008

Other Studies

2 other study(ies) available for fluorobenzenes and Parkinson Disease

ArticleYear
5-HT
    British journal of pharmacology, 2018, Volume: 175, Issue:2

    Topics: Animals; Carbazoles; Corpus Striatum; Fluorobenzenes; Locomotion; Male; Mice; Mitochondria; Organelle Biogenesis; Oxidopamine; Parkinson Disease; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Substantia Nigra; Tyrosine 3-Monooxygenase

2018
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.
    Behavioural pharmacology, 2011, Volume: 22, Issue:7

    Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Dyskinesias; Fenfluramine; Fluorobenzenes; Hyperkinesis; Male; Motor Activity; Oxidopamine; Parkinson Disease; Piperidines; Psychotic Disorders; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Sensory Gating; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents; Serotonin Receptor Agonists; Substantia Nigra; Tyrosine 3-Monooxygenase; Urea

2011